The Society for Experimental Hematology (ISEH) was established in 1950 by a group of scientists who sought to create a forum for the presentation and discussion of pre-clinical data in experimental hematology. ISEH continues to be dedicated to the promotion of the scientific knowledge and clinical application of basic hematologic and immunologic disorders through research, publications, and scientific programs. Incorporated in 1972 in the USA, the Society has over 800 active members from 40 countries around the world. Its annual scientific meeting attracts more than 500 participants over 4 days and, together with its official monthly journal Experimental Hematology, provides essential delivery of quality education, training programs, discussion forums, as well as promotes basic research.
ISEH members present their significant scientific breakthroughs such as research on cloning and characterization of many new hematopoietic growth factors, or the initial presentation of the work leading to Dr. Don Thomas’ Nobel Prize in Medicine. ISEH members were first to describe every known in vitro and in vivo assay for hematopoietic stem cells and progenitor cells (in vitro CFU-S, CFU-C, LTC-IC, CAFC assays and innovative in vivo transplantation assays). Others have developed and continuously redesigned methods for the purification of such cells from murine and human marrow and blood. Recent findings regarding the redirection of the fate of stem cells, signal transduction and transcription regulatory protein abnormalities in hematologic malignancies, and development of non-myeloablative hemopoietic stem and progenitor transplantation are just a few of the important discoveries presented in ISEH venues or publication.